Additionally, G6PD expression is strongly linked to OS and the immune microenvironment in HCC, and its overexpression lowers ferroptosis in HCC, underscoring its potential as a tumor prognostic and therapeutic biomarker [30]. The gene discussed is G6PD; the disease is hepatocellular carcinoma.